HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vascular imaging of solid tumors in rats with a radioactive arsenic-labeled antibody that binds exposed phosphatidylserine.

AbstractPURPOSE:
We recently reported that anionic phospholipids, principally phosphatidylserine, become exposed on the external surface of vascular endothelial cells in tumors, probably in response to oxidative stresses present in the tumor microenvironment. In the present study, we tested the hypothesis that a chimeric monoclonal antibody that binds phosphatidylserine could be labeled with radioactive arsenic isotopes and used for molecular imaging of solid tumors in rats.
EXPERIMENTAL DESIGN:
Bavituximab was labeled with (74)As (beta(+), T(1/2) 17.8 days) or (77)As (beta(-), T(1/2) 1.6 days) using a novel procedure. The radionuclides of arsenic were selected because their long half-lives are consistent with the long biological half lives of antibodies in vivo and because their chemistry permits stable attachment to antibodies. The radiolabeled antibodies were tested for the ability to image subcutaneous Dunning prostate R3227-AT1 tumors in rats.
RESULTS:
Clear images of the tumors were obtained using planar gamma-scintigraphy and positron emission tomography. Biodistribution studies confirmed the specific localization of bavituximab to the tumors. The tumor-to-liver ratio 72 h after injection was 22 for bavituximab compared with 1.5 for an isotype-matched control chimeric antibody of irrelevant specificity. Immunohistochemical studies showed that the bavituximab was labeling the tumor vascular endothelium.
CONCLUSIONS:
These results show that radioarsenic-labeled bavituximab has potential as a new tool for imaging the vasculature of solid tumors.
AuthorsMarc Jennewein, Matthew A Lewis, Dawen Zhao, Edward Tsyganov, Nikolai Slavine, Jin He, Linda Watkins, Vikram D Kodibagkar, Sean O'Kelly, Padmakar Kulkarni, Peter P Antich, Alex Hermanne, Frank Rösch, Ralph P Mason, Philip E Thorpe
JournalClinical cancer research : an official journal of the American Association for Cancer Research (Clin Cancer Res) Vol. 14 Issue 5 Pg. 1377-85 (Mar 01 2008) ISSN: 1078-0432 [Print] United States
PMID18316558 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal
  • Phosphatidylserines
  • Radioisotopes
  • Arsenic
Topics
  • Animals
  • Antibodies, Monoclonal (metabolism)
  • Arsenic (metabolism)
  • Endothelium, Vascular (metabolism)
  • Male
  • Neovascularization, Pathologic (diagnostic imaging)
  • Phosphatidylserines (metabolism)
  • Positron-Emission Tomography
  • Prostatic Neoplasms (blood supply)
  • Radioimmunodetection
  • Radioisotopes (metabolism)
  • Rats
  • Tissue Distribution
  • Tumor Cells, Cultured
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: